Anne Park
Nurse Practitioner · Las Vegas, NVNPI 1417650896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Gilead at 25.2% of the total. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $30.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- AstraZeneca$715
- AbbVie$499
- Bayer$382
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$375
- Amgen$366
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,736100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 32 | $1,446 |
| AstraZeneca | 22 | $715 |
| AbbVie | 12 | $499 |
| Bayer | 18 | $382 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $375 |
| Amgen(2 entities) | 14 | $366 |
| Novartis | 12 | $249 |
| Corcept Therapeutics | 6 | $218 |
| Lilly USA, LLC | 6 | $187 |
| Pfizer | 8 | $176 |
| Novo Nordisk | 6 | $151 |
| GSK | 6 | $132 |
| KCI USA, Inc. | 1 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $110 |
| Sanofi-aventis U.S. LLC | 3 | $77 |
| Ascensia Diabetes Care US Inc. | 1 | $75 |
| Dexcom, Inc. | 4 | $71 |
| Exact Sciences | 4 | $66 |
| Johnson & Johnson | 2 | $54 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Boehringer Ingelheim | 2 | $39 |
| Radius Health, Inc. | 1 | $38 |
| Mannkind Corporation | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,736 in reported general payments places this provider in the 90th percentile of 933 nurse practitioner providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $49,120 |
| JardianceEmpagliflozin | 20 | $25,735 |
| EliquisApixaban | 13 | $14,789 |
| FarxigaDapagliflozin Propanediol | 13 | $11,357 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $2,251 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $1,606 |
| Atorvastatin Calcium | 195 | $1,477 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,304 |
| Lidocaine | 11 | $1,069 |
| Ezetimibe | 17 | $802 |
| Amlodipine Besylate | 147 | $797 |
| Levothyroxine Sodium | 71 | $714 |
| Losartan Potassium | 104 | $712 |
| Metformin Hcl | 101 | $677 |
| Lisinopril | 124 | $660 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $151 | $49,12038 claims |
| Boehringer IngelheimJardiance | $39 | $25,73520 claims |
| PfizerEliquis | $176 | $14,78913 claims |
| AstraZenecaFarxiga | $715 | $11,35713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 933 nurse practitioner providers in Nevada.
Other nurse practitioner in Las Vegas
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
- Shannon SouthwickLas Vegas$32K
- Bonnie KwanLas Vegas$30K
- Amanda RalphLas Vegas$26K
- Teodoro AgtayLas Vegas$25K
- Katherine WhitmireLas Vegas$18K
- Jennifer WalshLas Vegas$18K
- Andrew VolinLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.